FDA Inspection 1109017 — New York Presbyterian Hospital Weill Cornell Medical College
The FDA completed an inspection of New York Presbyterian Hospital Weill Cornell Medical College on September 25, 2019 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 25, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)